In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
Manufacturing Standards: According to company materials, the company describes manufacturing in facilities that meet Good Manufacturing Practice (GMP) standards as defined by FDA regulations for dietary supplements
What to Expect in Month 1 Appetite changes: Noticeable suppression begins week 3-4 for most Mild nausea: 40% experience some nausea, usually mild Injection site reactions: Redness, itching, or mild pain at injection site (14% of patients) Fatigue: Some patients report low energy as body adjusts Bowel changes: Either constipation or looser stools as medication affects gut motility 4 Essential Strategies for Month 1 1
For Severe Deficiency and Medical Conditions : Hydroxocobalamin injections are preferred, especially if you need long-lasting effects or have absorption issues
The main differences are vial sizes (semaglutide commonly comes in 5 mg and 10 mg vials) and dosing ranges (semaglutide doses run 0.25 mg to 2.4 mg, lower than tirzepatide)
Visual indicators The appearance of lyophilized peptide provides the first clue about its condition